Oculoplastic and Craniofacial Service, Chelsea and Westminster Hospital, London, UK.
Curr Opin Ophthalmol. 2012 Sep;23(5):433-8. doi: 10.1097/ICU.0b013e3283560a99.
Orbital lymphangiomas present a difficult management problem for the ophthalmologist. This review offers a strategy for managing the condition.
There have been recent publications discussing the use of intralesional fibrin glue to aid dissection and intralesional sclerosant to shrink the lesion. We discuss the evidence for these treatments and present a case in which these treatments were combined.
This review highlights the classification and presents management options for orbital lymphangioma. We encourage a holistic and individualized approach to the patients, recognizing the variety of clinical manifestations that the condition can cause. In the event of surgical excision, we present the evidence for the use of intralesional fibrin glue and intralesional sclerosant, and describe using both in the same case.
眼眶淋巴管瘤的治疗对眼科医生来说是一个具有挑战性的问题。本文提供了一种处理这种疾病的策略。
最近有一些出版物讨论了使用腔内纤维蛋白胶辅助解剖和腔内硬化剂缩小病变。我们讨论了这些治疗方法的证据，并介绍了一个联合使用这些治疗方法的病例。
本文重点介绍了眼眶淋巴管瘤的分类，并提出了治疗选择。我们鼓励对患者进行全面和个性化的治疗，认识到该疾病可能导致的各种临床表现。在进行手术切除的情况下，我们提供了使用腔内纤维蛋白胶和腔内硬化剂的证据，并描述了在同一病例中同时使用这两种药物的情况。
